7Eriksson KF, Lindgarde F. Prevention of type 2 ( non-insulin-dependent) diabetes mellitus by diet and physical exercise. Diabetologia,1991,34 ( 12 ) :891-898.
8Tuomilehto J, Lindstrom J, Enksson JG, et al. Finnish diabetes prevention study group prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med,2001,344 ( 18 ): 1343-1350.
9Knowler WC, Barrett-Connor E, Fowler SE, et al. Diabetes prevention program research group reduction in the incidence of type 2 diabetes with lifestyle intervention or metfomin. N Engl J Med, 2002,346(6) :393-403.
10Swinburn BA, Metcalf PA, Ley S J, et al. Long-term (5-year) effects of a reduced fat diet intervention in individuals with glucose intolerance. Diabetes Care,2001,24(4) :619-623.
7Ananth J,Parameswaran S,Gunatilake S.Side effects of atypical an-tipsychotic drugs〔J〕. Current Pharmaceutical Design . 2004
8Baptista T,Kin NM,Beaulieu S,et al.Obesity and related metabolicabnormalities during antipsychotic drug administration:mechanisms,management and research perspectives〔J〕. Pharmacopsychiatria . 2002
9Pigott TA,Carson WH,Saha AR,et al.Aripiprazole for the preven-tion of relapse in stabilized patients with chronic schizophrenia:aplacebo-controlled 26-wddk study〔J〕. Journal of Clinical Psychiatry . 2003
10Nasrallah HA.Factors in antipsychotic drug selection:tolerability considerations. CNS Spectrums . 2003
